ArticleOncoTargets and therapy2018

Assessment of the cardiac safety between cetuximab and panitumumab as single therapy in Chinese chemotherapy-refractory mCRC.

Xue-Miao Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.